Skip to main content
Log in

Assessment of alveolar epithelial permeability in Behçet’s disease with 99mTc-DTPA aerosol scintigraphy

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Behçet’s disease (BD) is a multisystem disorder characterized by vasculitis, and consists of a triad of recurrent ulcers of the oral and genital mucosa with relapsing uveitis. The prevalance of pulmonary involvement varies in the range of 1–10% in various studies and its complications are severe and life threatening. In this study, we investigated the changes of pulmonary epithelial permeability of patients with BD using technetium-99m diethylene triamine penta-acetic acid (99mTc-DTPA) aerosol scintigraphy, so as to begin the therapy regimen as soon as possible.

Methods

Twenty-one nonsmoking patients with BD (8 women, 13 men; mean age 38.67 ± 8.86 years) and 15 healthy volunteer nonsmoking controls (8 women, 7 men; mean age 50.87 ± 12.45 years) underwent 99mTc-DTPA aerosol inhalation scintigraphy and pulmonary function tests (PFTs). Subjects inhaled 1480 MBq of 99mTc-DTPA for 4 min in the supine position. Scintigraphic data were recorded dynamically (1 frame/min) in the posterior projection on a 64 × 64 matrix for a 30-min period using a double-headed gamma camera (Infinia, GE, Tirat Hacarmel, Israel) equipped with a low-energy all-purpose parallel hole collimator. Half time of 99mTc-DTPA clearance (T 1/2) was calculated by placing a mono-exponential fit on the curves. Penetration index (PI) was also calculated by dividing the peripheral total counts by the sum of the peripheral and central total counts on the first minute image, in order to quantify the distribution of the inhaled aerosol.

Results

The clearance half time of 99mTc-DTPA radioaerosols in the BD patients (24.81 ± 6.22 min) was faster than in the normal control group (46.53 ± 22.41 min) (P = 0.004). There was also a significant difference between PI of the patients with BD (0.15 ± 0.03) and that of the controls (0.21 ± 0.06) (P = 0.002). No correlation was found between the mean T 1/2 values of 99mTc-DTPA clearance or the spirometric measurements in the BD patients. Penetration indices were not correlated with PFT in the BD patients.

Conclusions

Lung epithelial permeability of the patients with BD was significantly higher than that of the normal subjects. The results of this study demonstrated that the assessment of lung epithelial permeability using 99mTc-DTPA aerosol scintigraphy could predict the presence of lung involvement in the early stages of BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behçet disease: a cumulative analysis. Chest 2005;127:2243–2253.

    Article  PubMed  Google Scholar 

  2. Unlu M, Akincioglu C, Yamac K, Onder M. Pulmonary involvement in Behçet’s disease: evaluation of 123I-MIBG retention. Nucl Med Commun 2001;22:1083–1088.

    Article  PubMed  CAS  Google Scholar 

  3. Hiller N, Lieberman S, Chajek-Shaul T, Bar-Ziv J, Shaham D. Thoracic manifestation of Behçet disease at CT. Radio Graph 2004;24:801–808.

    Google Scholar 

  4. Akpolat T, Diri B, Oguz Y, Yilmaz E, Yavuz M, Dilek M. Behçet’s disease and renal failure. Nephrol Dial Transplant 2003;18:888–891.

    Article  PubMed  CAS  Google Scholar 

  5. Erkan F, Gul A, Tasali E. Pulmonary manifestations of Behçet’s disease. Thorax 2001;56:572–578.

    Article  PubMed  CAS  Google Scholar 

  6. Altıparmak MR, Tanverdi M, Pamuk ON, Tunc R, Hamuryudan V. Glomerulonephritis in Behçet’s disease: report of seven cases and review of the literature. Clin Rheumatol 2002;21:14–18.

    Article  PubMed  Google Scholar 

  7. Pupi A, Setsini S, De Cristofaro MTR, Emmi L, Marchione T, Salvati G, et al. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet’s disease. Eur J Nucl Med 2000;27:700–706.

    Article  PubMed  CAS  Google Scholar 

  8. Bozkurt MF, Basaran Demirkazık F, Emri S, Caner B. Ventilation-perfusion lung scan and helical computed tomographic findings in a patient with Behçet’s disease. Clin Nucl Med 2001;26:721–722.

    Article  PubMed  CAS  Google Scholar 

  9. Caglar M, Ergun E, Emri S. 99mTc-MAA lung scintigraphy in patients with Behçet’s disease: its value and correlation with clinical course and other diagnostic modalities. Nucl Med Commun 2000;21:171–179.

    Article  PubMed  CAS  Google Scholar 

  10. Kula M, Gulmez I, Tutus A, Coskun A, Gursoy S, Oymak S. Impaired lung epithelial permeability in hepatitis C virus antibody positive patients detected by 99mTc DTPA aerosol scintigraphy. Nucl Med Commun 2002;23:441–446.

    Article  PubMed  CAS  Google Scholar 

  11. Capa Kaya G, Durak H, Yemez B, Turhal U, Ozdogan O, Sayit E, et al. Technetium-99m DTPA inhalation scintigraphy in patients treated with fluoxetine and maprotiline: preliminary results. Eur J Nucl Med 2000;27:1402–1404.

    Article  PubMed  CAS  Google Scholar 

  12. Dalcin PTR, Barreto SSM, Cunha RD, Xavier RM, Brenol JCT, Marroni BJ. Lung of clearance 99mTc DTPA in systemic lupus erythematosus. Braz J Med Biol Res 2002;35:663–668.

    Article  PubMed  CAS  Google Scholar 

  13. Huglo D, De Botton S, Canva-Delcambre V, Colombel JF, Wallaert B, Steinling M, et al. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001;28:1504–1511.

    Google Scholar 

  14. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH. Transient increase in alveolar epithelial permeability induced by volatile anesthesia with isoflurane. Lung 2000;178:129–135.

    Article  PubMed  CAS  Google Scholar 

  15. Piga M, Passiu G, Carta P, Satta L, Cherchi V, Pala R, et al. Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression. Eur J Intern Med 2000;11:156–160.

    Article  PubMed  CAS  Google Scholar 

  16. Guldiken S, Tugrul A, Altiay G, Hacimahmutoglu S, Durmus-Altun G. Clearance of technetium-99m-labelled DTPA in hyperthyroidism without clinical evidence of lung disease, and relation to pulmonary function. Ann Nucl Med 2005;19:529–533.

    Article  Google Scholar 

  17. Antoniou KM, Malagari K, Tzanakis N, Perisinakis K, Symvoulakis EK, Karkavitkas N, et al. Clearance of technetium-99m-DTPA and HRCT findings in evaluation of patients with idiopathic pulmonary fibrosis. BMC Pulm Med 2006;6:4.

    Article  PubMed  CAS  Google Scholar 

  18. Uzal C, Durmus-Altun G, Caloglu M, Ergulen A, Altaner S, Yigitbasi O. The protective effect of Amifostine on radiationinduced acute pulmonary toxicity: detection by 99mTc-DTPA transalveolar clearances. Int J Radiat Oncol Biol Phys 2004;60:564–569.

    Article  PubMed  CAS  Google Scholar 

  19. Watanabe N, Tanada S, Sasaki Y. Pulmonary clearance of aerosolized 99mTc-DTPA in sarcoidosis I patients. Q J Nucl Med Mol Imaging 2006;50:1–9.

    Google Scholar 

  20. Gursoy S, Guven K, Kula M, Canoz O, Yurci A, Unluhizarci K, et al. Subclinical alveolar involvement in ulcerative colitis. Inflamm Bowel Dis 2005;11:372–375.

    Article  PubMed  Google Scholar 

  21. Mousa K, Onadeko BO, Mustafa HT, Mohamed M, Nabilla A, Omar A, et al. Technetium 99mTc-DTPA clearance in the evaluation of pulmonary involvement in patients with diabetes mellitus. Respir Med 2000;94:1053–1056.

    Article  PubMed  CAS  Google Scholar 

  22. Sayit E, Aktoğu S, Ertay T, Capa G, Erkmen G, Ozbilek E, et al. Effect of chemotherapy on pulmonary epithelial permeability in lung cancer. Nucl Med Biol 2000;27:581–585.

    Article  PubMed  CAS  Google Scholar 

  23. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Pérez-Padilla R, Jardim JR. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res 2007;40:887–895.

    Article  PubMed  CAS  Google Scholar 

  24. Kasikcioglu E, Akhan H, Cuhadaroglu C, Erkan F. Pulmonary artery aneurysm in Behcet’s disease: a case report. Heart Vessels; 2004;19:157–159.

    Article  PubMed  Google Scholar 

  25. Uysal H, Balevi S, Okudan N, Gokbel H. The relationship between HRCT and pulmonary function in Behcet’s disease. Lung 2004;182:9–14.

    Article  PubMed  CAS  Google Scholar 

  26. Ozer C, Duce MN, Ulubas B, Bicer A, Tursen U, Apaydin FD, et al. Inspiratory and expiratory HRCT finding in Behcet’s disease and correlation with pulmonary function tests. Eur J Radiol 2005;56:43–47.

    Article  PubMed  Google Scholar 

  27. Buxton-Thomas M, Higenbottam JL, Barber R, Wraight P. Clearance of inhaled 99mTc-DTPA from regions of the lung recently affected by pulmonary embolus. Bull Eur Physiopathol Respir 1986;22:55–60.

    PubMed  CAS  Google Scholar 

  28. Mori Y, Alderson PO, Berman HL. Effect of acute experimental pulmonary arterial occlusion on the deposition and clearance of technetium-99m-DTPA radioaerosols. J Nucl Med 1994;35:1351–1357.

    PubMed  CAS  Google Scholar 

  29. Cooper JA, Van der Zee H, Line BR, Malik AB. Relationship of end-expiratory pressure, lung volume, and 99mTc-DTPA clearance. J Appl Physiol 1987;63:1586–1590.

    PubMed  CAS  Google Scholar 

  30. Isawa T, Teshima T, Hirano T, Ebina A, Anazawa Y, Konno K. Mucociliary clearance in pulmonary vascular disease. Ann Nucl Med 1988;2:41–47.

    Article  PubMed  CAS  Google Scholar 

  31. Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, Dubois RM. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797–802.

    PubMed  CAS  Google Scholar 

  32. O’Doherty MJ, Peters AM. Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury. Eur J Nucl Med 1997;24:81–87.

    Article  PubMed  CAS  Google Scholar 

  33. Caner B, Ugur O, Bayraktar M, Ulutuncel N, Mentes T, Telatar F, et al. Impaired lung epithelial permeability in diabetics detected by technetium-99m-DTPA aerosol scintigraphy. J Nucl Med 1994;35:204–206.

    PubMed  CAS  Google Scholar 

  34. Ozsahin K, Tugrul A, Mert S, Yuksel M, Tugrul G. Evaluation of pulmonary alveolo-capillary permeability in type 2 diabetes mellitus using technetium 99mTc-DTPA aerosol scintigraphy and carbon monoxide diffusion capacity. J Diabetes Complications 2006;20:205–209.

    Article  PubMed  Google Scholar 

  35. Tsai SC, Kao CH, Lee JK, Wang SJ. The relationships between the radionuclide alveolar integrity study and the pulmonary function test. Kaohsiung J Med Sci 1996;12:88–92.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fikriye G. Gumuser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gumuser, F.G., Pirildar, T., Batok, D. et al. Assessment of alveolar epithelial permeability in Behçet’s disease with 99mTc-DTPA aerosol scintigraphy. Ann Nucl Med 22, 349–355 (2008). https://doi.org/10.1007/s12149-007-0138-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0138-4

Keywords

Navigation